VISION PHARMA specializes in niche pharmaceuticals that offer various therapeutic benefits to patients with the ability to improve the lives of those that take our medicines.  Our company has been in business for over 20 years and the 2 business partners have more than 60 years of combined Pharmaceutical/Medical experience.  Currently, the organization has been granted 3 UPSTO Patents, 1. Diphenhydramine, 2. Doxylamine, & 3. Dextromethorphan, utilizing a unique delivery system of strategically combining carbonation with liquids that should produce a faster onset of action, increased absorption of the API, more profound effect of the drug(s), significant taste compliance, and longer stability life.  This technology comes offered wwith other drugs, nutritionals, and herbals.  Sleep, Pain, Allergy, and Anit-Nausea pinpoint key indications for targeted markets.  Specific flavors, sizes, bottles, cans, and packaging configurations can be developed for the US or a regulatory approved country of origin.